Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Vincerx Pharma Q4 EPS $0.31

Vincerx Pharma (NASDAQ:VINC) reported quarterly earnings of $0.31 per share.
byBenzinga Newsdesk
March 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Vincerx Pharma (NASDAQ:VINC) reported quarterly earnings of $0.31 per share.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Novartis and Medicines for Malaria Venture Announce Decision to Move to Phase 3 Study for Novel Ganaplacide/lumefantrine-SDF Combination in Adults and Children With Malaria

By Charles Gross
Today, 11:36 PM
As the threat of resistance to current malaria treatments grows1,2, Novartis and MMV announce the decision to progress ganaplacide/lumefantrine- solid dispersion formulation (SDF) into Phase 3 development for the treatment of patients with acute uncomplicated malaria due to Plasmodium falciparum.

NVS